Stay updated on Tucatinib Combo in HER2+ LMD Clinical Trial
Sign up to get notified when there's something new on the Tucatinib Combo in HER2+ LMD Clinical Trial page.

Latest updates to the Tucatinib Combo in HER2+ LMD Clinical Trial page
- Check3 days agoChange DetectedFooter revision text updated from v3.6.3 to v3.6.4, indicating a minor platform update. No substantive study content or navigation changes are affected.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedAn updated page revision is shown: v3.6.3 replaces the previous v3.6.2 in the record history. This indicates a minor UI/version update to the page and does not affect study data or content.SummaryDifference0.1%

- Check32 days agoChange DetectedA new revision entry v3.6.2 was added to the study history, replacing the previous v3.6.0 and indicating an updated version of the record on ClinicalTrials.gov.SummaryDifference0.1%

- Check47 days agoChange DetectedVersion v3.6.0 was added, replacing v3.5.5. The entry also notes that no longer looking for participants, indicating recruitment has ended.SummaryDifference0.5%

- Check54 days agoChange DetectedThe page history now records a new revision, v3.5.5, replacing the previous v3.5.4. This signals a minor update to the page release.SummaryDifference0.1%

- Check75 days agoChange DetectedRecord History now shows Revision: v3.5.4, replacing Revision: v3.5.3. This reflects a site-wide release update rather than any change to the study record itself.SummaryDifference0.1%

Stay in the know with updates to Tucatinib Combo in HER2+ LMD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tucatinib Combo in HER2+ LMD Clinical Trial page.